[ad_1]
Modern AFP-Yonhap via The Korea Herald / Asia News Network
SEOUL – The American biotech firm Moderna is scheduled to provide 40 million doses of the Moderna COVID-19 vaccine starting in May, according to news reports on Friday.
The move came after the Korean government on Thursday signed an agreement with the company to buy doses of vaccines for 20 million people or more.
“Under the terms of the proposed agreement, deliveries would begin in May 2021,” the company said in a statement. “The COVID-19 vaccine is not currently approved for use in South Korea, and the company will work with regulators to obtain the necessary approvals prior to distribution.”
The Modern COVID-19 vaccine, which is licensed for emergency use in the United States and Canada, has not been officially approved in South Korea.
After the supply, the country will ensure enough vaccines for 56 million people in total, which can cover the country’s population of nearly 52 million, according to Cheong Wa Dae.
Meanwhile, the country added 1,029 more COVID-19 cases on Thursday at midnight, including 1,004 local infections, bringing the total number of cases to 61,769, according to the Korea Agency for Disease Prevention and Control.
For more news on the new coronavirus, click here.
What you need to know about the coronavirus.
For more information on COVID-19, call the DOH hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our leaders in healthcare and still accepts cash donations to be deposited into the Banco de Oro (BDO) checking account # 007960018860 or donate through PayMaya using this link .
Read next
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer and more than 70 other titles, share up to 5 gadgets, listen to the news, download from 4am and share articles on social media. Call 896 6000.
For comments, complaints or inquiries, please contact us.
[ad_2]
